Baricitinib for treatment of ustekinumab-induced paradoxical eczematous reactions in a patient with plaque psoriasis
European Journal of Dermatology · 2026-06 · 36 (3) · 266-267
DOI: 10.1684/ejd.2026.5077 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Dermatology, 2026-06. Verfasst von Chinatsu Shobatake und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Shobatake, C., Miyagawa, F., Mitsui, Y., Nakanishi, Y., Ogawa, K., & Asada, H. (2026). Baricitinib for treatment of ustekinumab-induced paradoxical eczematous reactions in a patient with plaque psoriasis. European Journal of Dermatology, 36(3), 266-267. https://doi.org/10.1684/ejd.2026.5077
Vancouver
Shobatake C, Miyagawa F, Mitsui Y, Nakanishi Y, Ogawa K, Asada H. Baricitinib for treatment of ustekinumab-induced paradoxical eczematous reactions in a patient with plaque psoriasis. European Journal of Dermatology. 2026;36(3):266-267. doi:10.1684/ejd.2026.5077
BibTeX
@article{Shobatake2026,
author = {Shobatake, Chinatsu and Miyagawa, Fumi and Mitsui, Yasuhiro and Nakanishi, Yukiko and Ogawa, Kohei and Asada, Hideo},
title = {Baricitinib for treatment of ustekinumab-induced paradoxical eczematous reactions in a patient with plaque psoriasis},
journal = {European Journal of Dermatology},
year = {2026},
volume = {36},
number = {3},
pages = {266--267},
doi = {10.1684/ejd.2026.5077}
}
EUVIMED